Medical Marijuana Card for Multiple Sclerosis

Multiple sclerosis and the muscle spasticity it causes are listed qualifying conditions in nearly every state program.

MS patients most commonly use cannabis for spasticity, neuropathic pain, and sleep. Nabiximols (Sativex), a cannabis-derived oral spray, is approved for MS spasticity in over 25 countries, and the National Academies review found moderate-to-substantial evidence for patient-reported spasticity improvement.

Because MS is managed with disease-modifying therapies, coordinate cannabis use with your neurologist. Certification appointments focus on your symptom profile and current regimen.

The information on this site is for educational purposes only and is not medical or legal advice. Cannabis use carries risks; consult a licensed physician about whether medical cannabis is appropriate for you. Federal status (as of June 2026): marijuana dispensed under state medical licenses and FDA-approved cannabis products are Schedule III controlled substances; all other marijuana remains Schedule I under U.S. federal law.

FAQ

Multiple Sclerosis questions

Will cannabis interact with my MS medications?

Interactions with disease-modifying therapies are not well documented, but sedation can stack with other medications. Review your full medication list with the certifying physician.

Which states accept multiple sclerosis for a medical marijuana card?

Most programs cover it: 32 states list multiple sclerosis explicitly — including Alabama, Alaska, Arizona, California, Colorado — and 7 more use physician-discretion standards where a doctor can certify it case by case.

Medical sources & references

NASEM 2017 — Multiple Sclerosis Spasticity — National Academies, 2017.Substantial evidence oral cannabinoids improve patient-reported spasticity
NCCIH — Cannabis and Cannabinoids: Multiple Sclerosis — NIH / NCCIH, 2019.Review of 17 studies (3,161 participants): small improvements in spasticity, pain, bladder symptoms
The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research — National Academies of Sciences, Engineering, and Medicine, 2017.Comprehensive evidence review underpinning condition-level statements
Cannabis (Marijuana) and Cannabinoids: What You Need To Know — National Center for Complementary and Integrative Health, NIH, 2019.NIH evidence summaries by condition

This page summarizes the cited evidence reviews; it does not make treatment claims beyond them. Discuss your specific situation with a licensed physician.

Talk to a doctor about multiple sclerosis

A licensed physician will tell you honestly whether you qualify — and you pay nothing if you don't.

Schedule Your Evaluation